Science

Drew Moghanaki: Enough is enough for TACE

gastroclinix.com

Feb 6, 2025, 13:33

Drew Moghanaki: Enough is enough for TACE

Drew Moghanaki, Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA, reshared the post by Yakup Ergün, Medical Oncologist at Antalya City Hospital, on X, adding:

“I trust the day is coming when all MEDICAL ONCOLOGISTS will stand up and say enough is enough for TACE.”

Quoting Yakup Ergün‘s post:

“Meta‐analysis of randomized controlled trials of external‐beam radiation versus TACE for HCC.

Pooled analysis of 3 RCTs.

Compared with TACE, EBRT yields superior local control and PFS early and intermediate stage HCC.”

Drew Moghanaki: Enough is enough for TACE

Meta-analysis of randomized controlled trials of external-beam radiation versus transarterial chemoembolization for hepatocellular carcinoma.

Authors: Ryan A. Kuehnle BS, et al.

Drew Moghanaki: Enough is enough for TACE

Antalya City Hospital cancer Drew Moghanaki EBRT fight against cancer Global fight against cancer HCC hepatocellular carcinoma MedOnc OncoDaily Oncology RadOnc Ryan A. Kuehnle BS TACE transarterial chemoembolization UCLA Yakup Ergün

April is Head and Neck Cancer Awareness Month

Is Cancer Hereditary? Myths and Facts about Cancer Genetics

Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates

Cancer Center Near Me: Dana-Farber Cancer Institute

FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial